Literature DB >> 29517056

Expanding incentives for coordinated, patient-centered care: Implications for neurologists.

William G Mantyh1, Bruce H Cohen1, Luana Ciccarelli1, Lindsey M Philpot1, Lyell K Jones1.   

Abstract

Historically, payment for cognitive, nonprocedural care has required provision of face-to-face evaluation and management as part of general ambulatory or inpatient care. Although non-face-to-face patient care (e.g., care via electronic means or telephone) is commonly performed and is integral to patient-centered care, appropriate reimbursement for this type of care is lacking. Beginning in 2017, Centers for Medicare and Medicaid (CMS) has taken a large step forward in reimbursing an increased number of cognitive care and non-face-to-face codes. CMS has also included language indicating that nonphysician providers (i.e., nurse practitioners and physician assistants) can perform many of these services independently. The 2017 and now the 2018 fee schedules thus create new payments for non-face-to-face, patient-centered services, and may allow neurologists to reach out to more patients through nonphysician providers. As health care in the United States moves toward value-based incentives, these newly supported non-face-to-face services will provide neurologists with new tools to deliver sustainable, high-value care.

Entities:  

Year:  2018        PMID: 29517056      PMCID: PMC5839681          DOI: 10.1212/CPJ.0000000000000426

Source DB:  PubMed          Journal:  Neurol Clin Pract        ISSN: 2163-0402


  23 in total

Review 1.  The enduring and evolving nature of the patient-physician relationship.

Authors:  D Roter
Journal:  Patient Educ Couns       Date:  2000-01

Review 2.  Telemedicine, telehealth, and mobile health applications that work: opportunities and barriers.

Authors:  Ronald S Weinstein; Ana Maria Lopez; Bellal A Joseph; Kristine A Erps; Michael Holcomb; Gail P Barker; Elizabeth A Krupinski
Journal:  Am J Med       Date:  2013-10-29       Impact factor: 4.965

3.  Medicare payments to the neurology workforce in 2012.

Authors:  Lesli E Skolarus; James F Burke; Brian C Callaghan; Amanda Becker; Kevin A Kerber
Journal:  Neurology       Date:  2015-04-01       Impact factor: 9.910

4.  Introducing the Axon Registry: An opportunity to improve quality of neurologic care.

Authors:  Bruce Sigsbee; James N Goldenberg; Christopher T Bever; Becky Schierman; Lyell K Jones
Journal:  Neurology       Date:  2016-09-30       Impact factor: 9.910

Review 5.  Telehealth among US hospitals: several factors, including state reimbursement and licensure policies, influence adoption.

Authors:  Julia Adler-Milstein; Joseph Kvedar; David W Bates
Journal:  Health Aff (Millwood)       Date:  2014-02       Impact factor: 6.301

6.  Fee-For-Service, While Much Maligned, Remains The Dominant Payment Method For Physician Visits.

Authors:  Samuel H Zuvekas; Joel W Cohen
Journal:  Health Aff (Millwood)       Date:  2016-03       Impact factor: 6.301

7.  Unique Educational Opportunities for PCPs and Specialists Arising From Electronic Consultation Services.

Authors:  Erin J Keely; Douglas Archibald; Delphine S Tuot; Heather Lochnan; Clare Liddy
Journal:  Acad Med       Date:  2017-01       Impact factor: 6.893

8.  Beyond capitation: how new payment experiments seek to find the 'sweet spot' in amount of risk providers and payers bear.

Authors:  Austin B Frakt; Rick Mayes
Journal:  Health Aff (Millwood)       Date:  2012-09       Impact factor: 6.301

9.  Allocation of Physician Time in Ambulatory Practice: A Time and Motion Study in 4 Specialties.

Authors:  Christine Sinsky; Lacey Colligan; Ling Li; Mirela Prgomet; Sam Reynolds; Lindsey Goeders; Johanna Westbrook; Michael Tutty; George Blike
Journal:  Ann Intern Med       Date:  2016-09-06       Impact factor: 25.391

10.  Crossing the telemedicine chasm: have the U.S. barriers to widespread adoption of telemedicine been significantly reduced?

Authors:  Cynthia LeRouge; Monica J Garfield
Journal:  Int J Environ Res Public Health       Date:  2013-11-28       Impact factor: 3.390

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.